These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4625697)

  • 1. [Blood levels of cephalothin in normal and impaired renal function].
    Höffler D; Koeppe P; Fuchs E; Fiegel P
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):450-9. PubMed ID: 4625697
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics of cephalothin].
    Höffler D; Koeppe P; Fuchs E; Fiegel P
    Verh Dtsch Ges Inn Med; 1971; 77():1019-22. PubMed ID: 5005541
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relationship between plasma cephalothin clearance and endogenous creatinine clearance. V].
    Sieniawska M; Wróblewska-Kałuzewska M; Białasik D; Karczeńska J; Wierzba K
    Pediatr Pol; 1980 Jun; 55(6):699-705. PubMed ID: 7413318
    [No Abstract]   [Full Text] [Related]  

  • 4. [Level of cephalothin, ampicillin and cloxacillin in the blood serum in children with renal insufficiency].
    Gurnitski B; Siniavska M; Vrublevska-Kapuzhevska M; Vezhbovska-Lange B; Kornishevska Ia
    Vopr Okhr Materin Det; 1975 Apr; 20(4):12-4. PubMed ID: 1154677
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose equation for continuous intravenous infusion based on pharmacokinetics and its clinical applications on cephalothin.
    Otaya H; Hayashi Y
    Int J Clin Pharmacol; 1974 Sep; 10(2):117-23. PubMed ID: 4448552
    [No Abstract]   [Full Text] [Related]  

  • 6. Cefazolin vs cephalothin and cephaloridine. A comparison of their clinical pharmacology.
    Regamey C; Gordon RC; Kirby WM
    Arch Intern Med; 1974 Mar; 133(3):407-10. PubMed ID: 4811478
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cefazolin, a new broad-spectrum antibiotic (author's transl)].
    Simon C; Malerczyk V; Brahmstaedt E; Toeller W
    Dtsch Med Wochenschr; 1973 Dec; 98(51):2448-50. PubMed ID: 4767675
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative pharmacokinetics of cefazolin, cephalothin, cephacetril, and cephapirine after intravenous administration.
    Bergan T
    Chemotherapy; 1977; 23(6):389-404. PubMed ID: 923329
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative clinical pharmacology of intravenous cefoxitin and cephalothin.
    Sonneville PF; Kartodirdjo RR; Skeggs H; Till AE; Martin CM
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):397-403. PubMed ID: 971703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftazidime in patients with impaired renal function. Studies on pharmacokinetics and nephrotoxicity.
    Thurmann-Nielsen E; Walstad RA; Dahl K; Hellum KB
    J Chemother; 1989 Jul; 1(4 Suppl):534-5. PubMed ID: 16312519
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of cephalothin levels in human tissues].
    Plaue R; Fabricius K; Wysocki S
    Chirurg; 1974 Jun; 45(6):274-8. PubMed ID: 4409146
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum and dialyzate concentrations of intraperitoneal cephalothin in patients undergoing continuous ambulatory peritoneal dialysis.
    Münch R; Steurer J; Lüthy R; Siegenthaler W; Kuhlmann U
    Clin Nephrol; 1983 Jul; 20(1):40-3. PubMed ID: 6883818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of renal insufficiency and hemodialysis on cephacetrile pharmacokinetics].
    Nissenson AR; Levin NW; Parker RH
    Arzneimittelforschung; 1974 Sep; 24(9b):1470-3. PubMed ID: 4479806
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of lobaplatin (D-19466) in patients with advanced solid tumors, including patients with impaired renal of liver function.
    Welink J; Boven E; Vermorken JB; Gall HE; van der Vijgh WJ
    Clin Cancer Res; 1999 Sep; 5(9):2349-58. PubMed ID: 10499604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of Cefmenoxime in normal and impaired renal function.
    Höffler D; Koeppe P
    Arzneimittelforschung; 1983; 33(2):269-72. PubMed ID: 6303362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of renal function in clinical routine: which is the best method?].
    Saile P; Fiedler R; Markau S; Kuhn C; Osten B
    Dtsch Med Wochenschr; 2007 May; 132(20):1093-7. PubMed ID: 17492567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of glomerular filtration rate estimations to variations in creatinine methodology: a study in older patients.
    Lamb EJ; Wood J; Stowe HJ; O'Riordan SE; Webb MC; Dalton RN
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):11-8. PubMed ID: 15802027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function.
    Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
    Nephrol Dial Transplant; 2006 Jul; 21(7):1855-62. PubMed ID: 16524933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cephalothin handling in patients undergoing hemodialysis.
    Venuto RC; Plaut ME
    Antimicrob Agents Chemother (Bethesda); 1970; 10():50-2. PubMed ID: 5521375
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cephalothin dosage for children depending on the degree of renal failure and body weight VI].
    Sieniawska M; Wróblewska-Kałuzewska M; Białasik D; Wierzba K
    Pediatr Pol; 1980 Jun; 55(6):707-13. PubMed ID: 7413319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.